MYND Life Sciences (TSE:MYND) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MYND Life Sciences has announced a strategic debt reduction by converting over $800,000 of debt into equity, aligning leadership interests with shareholders. Additionally, the company has strengthened its board by appointing Lana Hoogenboom, a seasoned pharmaceutical executive, to advance its commercialization strategies.
For further insights into TSE:MYND stock, check out TipRanks’ Stock Analysis page.